MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model
about
Diffusion MRI in early cancer therapeutic response assessment.Predicting and monitoring cancer treatment response with diffusion-weighted MRI.Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts.Assessment of tumor response to tyrosine kinase inhibitorsAcute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.Assessing reproducibility of diffusion-weighted magnetic resonance imaging studies in a murine model of HER2+ breast cancer.
P2860
MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
MRI methods for evaluating the ...... a breast tumor xenograft model
@ast
MRI methods for evaluating the ...... a breast tumor xenograft model
@en
type
label
MRI methods for evaluating the ...... a breast tumor xenograft model
@ast
MRI methods for evaluating the ...... a breast tumor xenograft model
@en
prefLabel
MRI methods for evaluating the ...... a breast tumor xenograft model
@ast
MRI methods for evaluating the ...... a breast tumor xenograft model
@en
P2093
P2860
P356
P1476
MRI methods for evaluating the ...... a breast tumor xenograft model
@en
P2093
L J Wilmes
M M Moasser
N M Hylton
P2860
P304
P356
10.1002/JMRI.21737
P577
2009-05-01T00:00:00Z